MHLW: Condition Has Improved In 70% Of Cervical Cancer Vaccine Patients Receiving Treatment
This article was originally published in PharmAsia News
Executive Summary
A MHLW Japan research team now reports that the condition of about 70% of patients who continued treatment after inoculation with cervical cancer vaccine has improved, following incidents in which many Japanese women were hit with side effects such as severe pain.
A MHLW Japan research team now reports that the condition of about 70% of patients who continued treatment after inoculation with cervical cancer vaccine has improved, following incidents in which many Japanese women were hit with side effects such as severe pain. Of the 70 patients surveyed at 11 hospitals around Japan, 47 said their condition had improved, 22 reported no change, and one said her condition had worsened. Women have been receiving counseling and guidance on stretching exercises and MHLW Team leader Takahiro Ushida says that the decrease of anxiety in many women has been connected to an improvement in symptoms. (Click Here For More – Japanese Language
)
“70% Of Post-Vaccination Pain, Treatment Improved With Cervical Cancer Vaccine” - yomidr.yomiuri.co.jp (7/4/2014)